Francesca Sanchez
Overview
Explore the profile of Francesca Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scharf A, Mitteldorf J, Armstead B, Schneider D, Jin H, Kocsisova Z, et al.
Nat Comput Sci
. 2023 Nov;
2(2):90-101.
PMID: 37981946
Understanding populations is important because they are a fundamental level of biological organization. Individual traits such as aging and lifespan interact in complex ways to determine birth and death and...
2.
Santin M, Perez-Recio S, Grijota M, Anibarro L, Barcala J, De Souza-Galvao M, et al.
PLoS One
. 2022 Oct;
17(10):e0276387.
PMID: 36269714
Background And Purpose: Screening for and treatment of latent tuberculosis (TB) in patients with end-stage kidney disease (ESKD) are recommended. However, there is limited evidence on safety and treatment completion...
3.
Hamalian S, Guth R, Runa F, Sanchez F, Vickers E, Agajanian M, et al.
Oncogene
. 2021 Jul;
40(33):5224-5235.
PMID: 34239043
Intercellular mechanisms by which the stromal microenvironment contributes to solid tumor progression and targeted therapy resistance remain poorly understood, presenting significant clinical hurdles. PEAK1 (Pseudopodium-Enriched Atypical Kinase One) is an...
4.
Jove N, Masdeu E, Brugueras S, Millet J, Ospina J, Orcau A, et al.
Arch Bronconeumol (Engl Ed)
. 2020 Jun;
57(5):330-337.
PMID: 32593536
Background: Since there are active drugs against tuberculosis (TB), the most effective control measures are to assure treatment adherence and to perform contact tracing. Given the long treatment duration and...
5.
Meade K, Sanchez F, Aguayo A, Nadales N, Hamalian S, Uhlendorf T, et al.
Oncotarget
. 2019 May;
10(32):3027-3039.
PMID: 31105883
Cancer metastasis is responsible for the clear majority of cancer-related deaths. Survival and expansion of cancer cells at secondary sites requires that these premetastatic microenvironments be primed by primary tumor...
6.
Ospina J, Orcau A, Millet J, Sanchez F, Casals M, Cayla J
BMC Public Health
. 2012 Mar;
12:158.
PMID: 22394990
Background: The important increase in immigration during recent years has changed the epidemiology and control strategies for tuberculosis (TB) in many places. This study evaluates the effectiveness of intervention with...
7.
Portillo M, Sanchez F, Vicente E, Salvado M
Enferm Infecc Microbiol Clin
. 2011 Apr;
29(5):399-401.
PMID: 21470717
No abstract available.
8.
Sanchez F, Lopez Colomes J, Villarino E, Grosset J
Enferm Infecc Microbiol Clin
. 2011 Mar;
29 Suppl 1:47-56.
PMID: 21420567
Available data on anti-tuberculosis drug research reveal different properties of the agents and provoke speculation about future directions. Higher doses of the rifamycins are promising and are currently being evaluated...
9.
Moreno A, Sanchez F, Nelson J, Miro J, Cayla J
Gac Sanit
. 2009 Dec;
24(2):171.e1-6.
PMID: 20005019
New treatment guidelines are required to improve the tuberculosis control strategies that have been used for 30 years. Seven centers of the Barcelona Tuberculosis Research Unit (BTRU) (Unitat d'Investigació en...
10.
Borrell S, Espanol M, Orcau A, Tudo G, March F, Cayla J, et al.
J Clin Microbiol
. 2008 Nov;
47(1):198-204.
PMID: 19020067
The aim of this study was to analyze the factors associated with conventional contact tracing (CCT) and molecular epidemiology (ME) methods in assessing tuberculosis (TB) transmission, comparing the populations studied...